Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy. | Ann N Y Acad Sci;762: 359-60, 1995 Jul 21. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.

Ritch, P S; Keever, C; Schiller, J; Rivkin, S; Witt, P L; Grossberg, S E; Truitt, R L; Burris, H; von Hoff, D D; Vaickus, L.

Affiliation

Ritch PS; Medical College of Wisconsin, Milwaukee, USA.

Ann N Y Acad Sci ; 762: 359-60, 1995 Jul 21.

Article in En | MEDLINE | ID: mdl-7668536

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Neoplasms Limits: Humans Language: En Journal: Ann N Y Acad Sci Year: 1995 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Neoplasms Limits: Humans Language: En Journal: Ann N Y Acad Sci Year: 1995 Document type: Article Affiliation country: